Inhaltsverzeichnis
Cytogenetic Findings in Myeloproliferative Disorders. - Molecular Analyses of Chronic Myelocytic Leukemias. - Molecular Biological Investigation in Chronic Myelogenous Leukemia Patients Undergoing Interferon Therapie. - Effect of Recombinant Interferon-Alpha-2 on the Growth of Hematopoietic Progenitor Cells in Chronic Myelogenous Leukemia and Its Relationship to the Clinical Efficacy. - In Vitro Effects of Recombinant Human Tumor Necrosis Factor-Alpha and Interferon-Gamma on Normal and Leukemic Myelopoiesis. - Demonstration of Interferon-Alpha Receptors in Cultured Cell Lines and in Myeloid Cells from Patients with Acute or Chronic Myeloid Leukemia. - Differential Regulation of Cell Membrane Receptors for Interferon-Gamma and -Alpha on Peripheral Blood Cells of Patients with Chronic Myelogenous Leukemia During Interferon-Gamma/-Alpha Therapy. - Studies of Interferon as a Regulator on Hematopoietic Stem Cells in Chronic Myelogenous Leukemia. - Suppressive Effect of Interferon Alpha-2b on Hematopoietic Progenitor Cells in Patients with Chronic Myelogenous Leukemia. - Clinical Significance of Neutralizing Antibodies in Patients with Chronic Myelogenic Leukemia. - Cytostatic Therapy of Chronic Myelogenous Leukemia: Review and Perspectives. - In Vivo Effects of Interferon-gamma in Chronic Myelogenous Leukemia. - Treatment of Chronic and Acute Phase Chronic Myelogenous Leukemia with Interferon-Alpha-2b and Interferon-? . - Maintenance Therapy of Busulfan-Induced Chronic Granulocytic Leukemia Remissions with Interferon-Alpha-2b. - Allogeneic Bone Marrow Transplantation in Chronic Myelogenous Leukemia.